Noma: a reappraisal in Western countries - are HIV-negative immunocompetent adult patients safe?

M. Mascitti, A. Barlattani, L. Togni, F. Sampalmieri, G. Favia, L. Lo Muzio, A. Santarelli

Article ID: 5366
Vol 33, Issue 3, 2019
DOI: https://doi.org/10.54517/jbrha5366
Received: 16 October 2018; Accepted: 16 October 2018; Available online: 9 July 2019; Issue release: 9 July 2019

Keywords

Cancrum oris;immunocompetent patient;noma;type 2 Diabetes mellitus


References

Supporting Agencies



Copyright (c) 2019 M. Mascitti, A. Barlattani, L. Togni, F. Sampalmieri, G. Favia, L. Lo Muzio, A. Santarelli




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).